When rice is in its flowering and grain-filling stages, it is more sensitive to high nighttime temperatures than high daytime ...

Bengaluru-based biotechnology startup, CrisprBits Private Limited, has inaugurated a CRISPR gene editing and diagnostics ...

Along with its gene editing therapy Casgevy, Vertex is offering fertility preservation support for its patients—a program ...

With that in mind, let's consider two stocks that haven't performed well recently and are now near their 52-week lows but that are still worth investing in: CRISPR Therapeutics (NASDAQ: CRSP) and ...

"We’re in very different place," the CEO of Editas says, citing the CRISPR pioneer's plans to get its first treatments into ...

CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

EMERYVILLE, Calif. - Metagenomi, Inc. (NASDAQ: MGX), a biotechnology firm specializing in precision genetic medicines trading ...

A group of scientists says they will bring back the woolly mammoth by late 2028, and they just announced that they raised ...

(Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today provided updates on the successful ...

In BlueAllele Corp. v. Intellia Therapeutics, Inc., 2024 U.S. Dist. Lexis 222094 (D. Del. Dec. 9, 2024)1, the District of ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...

Colossal Biosciences, a leader in the emerging field of de-extinction, has raised $200 million in a Series C funding round.